These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27371370)

  • 21. The resilience of the intestinal microbiota influences health and disease.
    Sommer F; Anderson JM; Bharti R; Raes J; Rosenstiel P
    Nat Rev Microbiol; 2017 Oct; 15(10):630-638. PubMed ID: 28626231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The human gut microbiota].
    Knudsen JK; Bundgaard-Nielsen C; Hagstrøm S; Sørensen S; Leutscher P
    Ugeskr Laeger; 2017 Dec; 179(49):. PubMed ID: 29212595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease.
    Yan PG; Li JN
    Chin Med J (Engl); 2020 Apr; 133(7):834-841. PubMed ID: 32106123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.
    Khajah MA
    Scand J Gastroenterol; 2017 Nov; 52(11):1172-1184. PubMed ID: 28685630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microbiota and irritable bowel syndrome: A critical inventory].
    Enck P; Mazurak N
    Z Gastroenterol; 2019 Jul; 57(7):859-870. PubMed ID: 31288282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota: Diagnosing IBD with the gut microbiome.
    Dickson I
    Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):195. PubMed ID: 28250469
    [No Abstract]   [Full Text] [Related]  

  • 34. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
    Fuentes S; de Vos WM
    Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gut Microbiota in Inflammatory Bowel Disease.
    Sheehan D; Shanahan F
    Gastroenterol Clin North Am; 2017 Mar; 46(1):143-154. PubMed ID: 28164847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiome and diabetes: Where are we now?
    Vallianou NG; Stratigou T; Tsagarakis S
    Diabetes Res Clin Pract; 2018 Dec; 146():111-118. PubMed ID: 30342053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic and Modulation of Microbiota: A New Paradigm?
    Rizzatti G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.